Rheumatoid arthritis in pregnancy: Successful outcome with anti-TNF agent (Etanercept)

Journal of Obstetrics and Gynaecology

Volumn 26, Issue 7, 2006, Pages 689-691

  Sinha, A ^a,b   Patient, C ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b NONE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ETANERCEPT;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CESAREAN SECTION; CLINICAL FEATURE; FEMALE; FETUS GROWTH; HUMAN; PREGNANCY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; TREATMENT OUTCOME; ULTRASOUND;

ADULT; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; IMMUNOGLOBULIN G; PREGNANCY; PREGNANCY COMPLICATIONS; RECEPTORS, TUMOR NECROSIS FACTOR;

EID: 33750522009     PISSN: 01443615     EISSN: 13646893     Source Type: Journal    
DOI: 10.1080/01443610600930647     Document Type: Article

References (5)

1. Chakravarty EF, Sanchez-Yamamoto D, Bush TM. 2003. The use of disease modifying antirheumatic drugs in women with RA of child bearing age: a survey of practice patterns and pregnancy outcome. Journal of Rheumatology 30:241-246.
2. Kaplan D. 1986. Fetal wastage in patients with Rheumatoid Arthritis. Journal of Rheumatology 13:855-877.
3. Nelson JL, Voigt LF, Koepsell TD, Dugowson CE, Daling JR. 1992. Pregnancy outcome in women with rheumatoid arthritis before disease onset. Journal of Rheumatology 19:18-21.
4. Oka M, Vainio V. 1966. Effect of pregnancy on the prognosis and serology of rheumatoid arthritis. Acta Rhematologica Scandinavica 12:47-52.
5. Persellin RH. 1977. The effect of pregnancy on rheumatoid arthritis. Bulletin on the Rheumatic Diseases 27:922-927.